Release date: 2016-08-04
On August 1, 2016, the United States Space Agency (Roscosmos) state-owned enterprise United Rocket Space Corporation (URSC) announced that the company has signed an agreement with the country's 3D Bioprinting Solutions to develop a The magnetic 3D bioprinter running in a zero-gravity environment is scheduled to be sent to the International Space Station in 2018.
"This developed magnetic 3D bioprinter will be used to print tissue and organ structures that are highly sensitive to the effects of space radiation... for biomonitoring of the negative effects of cosmic radiation on organisms in long-term space-based environments. And use this to develop corresponding countermeasures," URSC said in a press release.
It is understood that the research part of this project will be led by Vladimir Mironov, Scientific Director of 3D Bioprinting Solutions. It is reported that 3D Bioprinting Solutions is the residence company of the Skolkovo Innovation Center. In fact, the company Tiangongshe had previously reported that the company last year claimed that the thyroid gland was first printed in 3D and transplanted to mice.
In announcing the news of the cooperation, URSC general manager Yuri Vlasov called it another step in the human effort to explore other planets. "In the deep space manned mission, this ability to create organs will support humanity in the new era of space exploration," he said.
At the same time, Youssef Hesuani of 3D Bioprinting Solutions believes that this project may also affect medical technology on the planet. This is a unique opportunity to find new methods and techniques in tissue engineering and regenerative medicine, he said. More importantly, 3D Bioprinting Solutions believes that their technology can accelerate the development of artificial human tissues and organs.
Source: Tiangongshe
Food Additives
Food Additives
XI'AN PLANT BIO-ENGINEERING CO.,LTD , https://www.plantbic.com